lobbying_activities: 2420405

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2420405	7d98892c-720a-4f6f-ab47-c67611f8b785	Q1	CRANE STRATEGIES	400927689	REGENERON PHARMACEUTICALS, INC.	2020	first_quarter	BUD	Biodefense funding; coronavirus supplemental funding	HOUSE OF REPRESENTATIVES,SENATE	50000		0	0	2020-03-30T13:34:53.143000-04:00